Rectal cancer how do you get it

Obezitate, indicele de masă corporală și risc de cancer |

Updates in Rectal Cancer

Ki is a marker of cell proliferation associated with a low survival in colorectal cancer patients. Its expression is increased in patients with Dukes C or D colorectal cancer versus those in stage A or B.

The purpose of the study is to evaluate the immunohistochemical expression of the Ki marker in colorectal adenocarcinomas.

în gură pe obrajii negilor

The study was performed on a group of 28 patients diagnosed with rectal cancer. We made the histopathological and immunohistochemical evaluation of patients in the study group.

medicamento para oxiuros ninos

The evaluation was performed on the sections stained with hematoxylin-eosin, and for mucinous forms, on sections stained with alcian blue. The topography of the Ki reaction is strictly nuclear, evident in areas with intense proliferative activity.

  • Rectal cancer medscape Rectal cancer metastases. Papiloma caracteristicas histopatologicas
  • Îndepărtarea chirurgicală a negilor
  • Papiloma en ano sintomas
  • Antibiotic giardien katze
  • Most small bowel cancers are revealed by a complication

In cases with a strong positive response to Ki, the prognosis is worse, with invasion of the perirectal tissues and metastases. The lack of Ki expression in nearby neoplastic tissues suggests that cancerous tissue proliferates in a pathway that it is not correlated with adjacent tissues. The Ki could be useful in the prognosis of patients with colorectal cancer.

cancer colon stade 4

Keywords: colorectal cancer; Ki immunohistochemical expression; prognosis Issue:Volume 70, Issue 1 Pages: